578 related articles for article (PubMed ID: 18001325)
1. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
[TBL] [Abstract][Full Text] [Related]
2. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K
Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
Ishibashi O; Yamagishi T; Hanada K; Kawashima H
Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-like activities of saikosaponin-d in vitro: a pilot study.
Wang P; Ren J; Tang J; Zhang D; Li B; Li Y
Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234
[TBL] [Abstract][Full Text] [Related]
10. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
Xia Y; Xing JZ; Krukoff TL
Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
Pettersson K; Delaunay F; Gustafsson JA
Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684
[TBL] [Abstract][Full Text] [Related]
14. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
15. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type.
Lima F; Vico L; Lafage-Proust MH; van der Saag P; Alexandre C; Thomas T
Bone; 2004 Nov; 35(5):1127-35. PubMed ID: 15542038
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
Chen XN; Zhu H; Meng QY; Zhou JN
Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
[TBL] [Abstract][Full Text] [Related]
17. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES).
Akbas GE; Song J; Taylor HS
J Mol Biol; 2004 Jul; 340(5):1013-23. PubMed ID: 15236964
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP.
Maharjan S; Serova L; Sabban EL
J Neurochem; 2005 Jun; 93(6):1502-14. PubMed ID: 15935066
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
